Healthcare

[WEBINAR] Dealmaking 2026: What’s Changing, What’s Not, and How to Position for the Next Wave

Healthcare Events replay

[WEBINAR] Biopharma Dealmaking 2026: Trends, Shifts, and What Comes Next

In this webinar, Ipsos will frame the latest dealmaking trends using recent transactions and market data, followed by a moderated discussion with active investors on what is changing in valuation, deal structures, and decision criteria, and what this means for pharma acquirers and innovator biotechs preparing for partnering conversations.

05.19.26

Men Survey

Most men say they don't encounter barriers to improving their health

A recent Ipsos/MDVIP poll finds men who have primary care doctors are more likely to have a better understanding of key men’s health issues

03.02.22

Consumers Publication

The Amazing Race 2022 Update: Next-Gen Immuno-Oncology Edition

Read our March 2022 update regarding the two front-runners in this niche category and insights behind their race to market.

03.01.22

Healthcare Survey

Americans frustrated with insurance coverage and costs

A new PhRMA/Ipsos poll finds that Americans worry about insurance coverage costs and would like to see more solutions around transparency and out-of-pockets costs from health care institutions.

03.01.22

COVID-19 Survey

What Worries the World - February 2022

The global public’s top 5 concerning issues remain unchanged, with Covid-19 still top. But inflation now ranks 6th with almost one in four (23%) worldwide now saying it is a worry in their country.

02.25.22

Healthcare Survey

American Healthcare Workers Persevering, but Remain Stressed

New USA Today-Ipsos survey of healthcare workers finds one in three thinks the system is on the verge of collapse

02.22.22

Healthcare Publication

Conquering Complexity: The ongoing revolution in oncology biomarker testing

The clinical management of cancer patients has undergone a remarkable evolution in the last 15 years, with the concept of personalized medicine now well-entrenched in the treatment paradigm.

02.04.22